Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Apoa5(ab) (AA 20-363) antibody

Reactivity: Human ELISA, WB Host: Mouse Monoclonal 1G5G9(c) unconjugated
Catalog No. ABIN969468
  • Target
    Apoa5(ab)
    Binding Specificity
    AA 20-363
    Reactivity
    Human
    Host
    Mouse
    Clonality
    • 1
    Monoclonal
    Conjugate
    • 1
    Un-conjugated
    Application
    ELISA, Western Blotting (WB)
    Purification
    purified
    Immunogen
    Purified recombinant fragment of human APOA5 (AA: 20-363) expressed in E. coli.
    Clone
    1G5G9(c)
    Isotype
    IgG1
  • Application Notes
    ELISA: 1:10000, WB: 1:500 - 1:2000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified antibody in PBS containing 0.03 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C/-20 °C
    Storage Comment
    4°C, -20°C for long term storage
  • Target
    Apoa5(ab)
    Alternative Name
    Apoa5 (ab)
    Background

    Description: Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglycerides, whereas a knock-in model with human ApoA5 produced 50-70 % lower , concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.

    Aliases: RAP3, APOAV, APOA-V

    Gene ID
    116519
    HGNC
    116519
You are here:
Support